| Rochelle Kelly, APRN | |
|
106 Highway 62 W, Salem, AR 72576-8059 | |
| (870) 895-2015 | |
| Not Available |
| Full Name | Rochelle Kelly |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 106 Highway 62 W, Salem, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093238875 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A005255 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Bernards Medical Center | Jonesboro, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Access Medical Clinic Arkansas Llc | 5890077093 | 136 |
| Access Medical Clinic Arkansas Ltc Llc | 0547618175 | 96 |
News Archive
An international team of scientists — led by researchers from the University of Washington and two other institutions — has announced that a new compound to fight malaria is ready for human trials. In a new paper published July 15 in Science Translational Medicine, they show that this compound is the first to cripple a critical protein that the malaria parasite needs to survive at different stages of its complex life cycle, and is suitable for clinical tests in humans.
In a study that included approximately 85,000 Norwegian children, maternal use of supplemental folic acid from 4 weeks before to 8 weeks after the start of pregnancy was associated with a lower risk of autistic disorder in children, according to a study appearing in the February 13 issue of JAMA.
Researchers in Heidelberg and Stanford have discovered a new signalling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis in check. The peptide angiotensin not only raises blood pressure but also activates the immunological messenger substance TGF beta on a previously unknown communication pathway in the brain.
When kids head back to school this fall, for some it will be the first time they've been in a real classroom with other students since the pandemic began.
› Verified 8 days ago
| Entity Name | Bradley Bibb Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699097436 PECOS PAC ID: 4789715285 Enrollment ID: O20100628000488 |
News Archive
An international team of scientists — led by researchers from the University of Washington and two other institutions — has announced that a new compound to fight malaria is ready for human trials. In a new paper published July 15 in Science Translational Medicine, they show that this compound is the first to cripple a critical protein that the malaria parasite needs to survive at different stages of its complex life cycle, and is suitable for clinical tests in humans.
In a study that included approximately 85,000 Norwegian children, maternal use of supplemental folic acid from 4 weeks before to 8 weeks after the start of pregnancy was associated with a lower risk of autistic disorder in children, according to a study appearing in the February 13 issue of JAMA.
Researchers in Heidelberg and Stanford have discovered a new signalling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis in check. The peptide angiotensin not only raises blood pressure but also activates the immunological messenger substance TGF beta on a previously unknown communication pathway in the brain.
When kids head back to school this fall, for some it will be the first time they've been in a real classroom with other students since the pandemic began.
› Verified 8 days ago
| Entity Name | Access Medical Clinic Arkansas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578007647 PECOS PAC ID: 5890077093 Enrollment ID: O20170124001288 |
News Archive
An international team of scientists — led by researchers from the University of Washington and two other institutions — has announced that a new compound to fight malaria is ready for human trials. In a new paper published July 15 in Science Translational Medicine, they show that this compound is the first to cripple a critical protein that the malaria parasite needs to survive at different stages of its complex life cycle, and is suitable for clinical tests in humans.
In a study that included approximately 85,000 Norwegian children, maternal use of supplemental folic acid from 4 weeks before to 8 weeks after the start of pregnancy was associated with a lower risk of autistic disorder in children, according to a study appearing in the February 13 issue of JAMA.
Researchers in Heidelberg and Stanford have discovered a new signalling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis in check. The peptide angiotensin not only raises blood pressure but also activates the immunological messenger substance TGF beta on a previously unknown communication pathway in the brain.
When kids head back to school this fall, for some it will be the first time they've been in a real classroom with other students since the pandemic began.
› Verified 8 days ago
| Entity Name | Access Medical Clinic Arkansas Ltc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114578929 PECOS PAC ID: 0547618175 Enrollment ID: O20231208000065 |
News Archive
An international team of scientists — led by researchers from the University of Washington and two other institutions — has announced that a new compound to fight malaria is ready for human trials. In a new paper published July 15 in Science Translational Medicine, they show that this compound is the first to cripple a critical protein that the malaria parasite needs to survive at different stages of its complex life cycle, and is suitable for clinical tests in humans.
In a study that included approximately 85,000 Norwegian children, maternal use of supplemental folic acid from 4 weeks before to 8 weeks after the start of pregnancy was associated with a lower risk of autistic disorder in children, according to a study appearing in the February 13 issue of JAMA.
Researchers in Heidelberg and Stanford have discovered a new signalling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis in check. The peptide angiotensin not only raises blood pressure but also activates the immunological messenger substance TGF beta on a previously unknown communication pathway in the brain.
When kids head back to school this fall, for some it will be the first time they've been in a real classroom with other students since the pandemic began.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rochelle Kelly, APRN 49 Highway 62 412, Ash Flat, AR 72513-9594 Ph: (870) 994-7301 | Rochelle Kelly, APRN 106 Highway 62 W, Salem, AR 72576-8059 Ph: (870) 895-2015 |
News Archive
An international team of scientists — led by researchers from the University of Washington and two other institutions — has announced that a new compound to fight malaria is ready for human trials. In a new paper published July 15 in Science Translational Medicine, they show that this compound is the first to cripple a critical protein that the malaria parasite needs to survive at different stages of its complex life cycle, and is suitable for clinical tests in humans.
In a study that included approximately 85,000 Norwegian children, maternal use of supplemental folic acid from 4 weeks before to 8 weeks after the start of pregnancy was associated with a lower risk of autistic disorder in children, according to a study appearing in the February 13 issue of JAMA.
Researchers in Heidelberg and Stanford have discovered a new signalling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis in check. The peptide angiotensin not only raises blood pressure but also activates the immunological messenger substance TGF beta on a previously unknown communication pathway in the brain.
When kids head back to school this fall, for some it will be the first time they've been in a real classroom with other students since the pandemic began.
› Verified 8 days ago
Mrs. Shira Lanae Turner, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 679 N Main St, Salem, AR 72576 Phone: 870-895-2691 | |
Ellen Weseli Ward, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 106 Highway 62 W, Salem, AR 72576 Phone: 870-895-2015 Fax: 870-895-2164 | |
Ashley Brooke Merritt, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 106 Highway 62 W, Salem, AR 72576 Phone: 870-895-2015 | |
Whitley Erin Hill, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 106 Highway 62 W, Salem, AR 72576 Phone: 870-895-2015 Fax: 870-895-2164 | |
Naomi Harrod, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 106 Highway 62 W, Salem, AR 72576 Phone: 870-895-2015 Fax: 870-895-2164 | |
Amy Hodges, APRN, CPNP-PC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 172 Highway 62 W, Salem, AR 72576 Phone: 870-895-2735 Fax: 870-895-2709 |